Venture Life Group (VLG) Competitors GBX 40.50 -1.00 (-2.41%) (As of 11/15/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesInsider Trades VLG vs. BVXP, INS, ARIX, HVO, 4BB, AVCT, FARN, SCLP, ANCR, and CIRShould you be buying Venture Life Group stock or one of its competitors? The main competitors of Venture Life Group include Bioventix (BVXP), Instem (INS), Arix Bioscience (ARIX), hVIVO (HVO), 4basebio (4BB), Avacta Group (AVCT), Faron Pharmaceuticals Oy (FARN), Scancell (SCLP), Animalcare Group (ANCR), and Circassia Group (CIR). These companies are all part of the "medical" sector. Venture Life Group vs. Bioventix Instem Arix Bioscience hVIVO 4basebio Avacta Group Faron Pharmaceuticals Oy Scancell Animalcare Group Circassia Group Venture Life Group (LON:VLG) and Bioventix (LON:BVXP) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, profitability, analyst recommendations, community ranking, risk, dividends, earnings and valuation. Does the MarketBeat Community prefer VLG or BVXP? Venture Life Group received 64 more outperform votes than Bioventix when rated by MarketBeat users. Likewise, 72.90% of users gave Venture Life Group an outperform vote while only 52.87% of users gave Bioventix an outperform vote. CompanyUnderperformOutperformVenture Life GroupOutperform Votes15672.90% Underperform Votes5827.10% BioventixOutperform Votes9252.87% Underperform Votes8247.13% Which has stronger earnings and valuation, VLG or BVXP? Bioventix has lower revenue, but higher earnings than Venture Life Group. Bioventix is trading at a lower price-to-earnings ratio than Venture Life Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVenture Life Group£51.41M1.00£2.64M£0.014,050.00Bioventix£13.60M14.68£8.67M£1.632,346.63 Does the media refer more to VLG or BVXP? In the previous week, Venture Life Group and Venture Life Group both had 1 articles in the media. Bioventix's average media sentiment score of 0.75 beat Venture Life Group's score of 0.30 indicating that Bioventix is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Venture Life Group 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Bioventix 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more risk and volatility, VLG or BVXP? Venture Life Group has a beta of 0.3, indicating that its share price is 70% less volatile than the S&P 500. Comparatively, Bioventix has a beta of 0.35, indicating that its share price is 65% less volatile than the S&P 500. Do insiders and institutionals believe in VLG or BVXP? 69.5% of Venture Life Group shares are held by institutional investors. Comparatively, 62.3% of Bioventix shares are held by institutional investors. 10.4% of Venture Life Group shares are held by company insiders. Comparatively, 8.0% of Bioventix shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Is VLG or BVXP more profitable? Bioventix has a net margin of 63.73% compared to Venture Life Group's net margin of 1.44%. Bioventix's return on equity of 79.14% beat Venture Life Group's return on equity.Company Net Margins Return on Equity Return on Assets Venture Life Group1.44% 1.00% 1.56% Bioventix 63.73%79.14%54.07% SummaryBioventix beats Venture Life Group on 8 of the 14 factors compared between the two stocks. Ad DarwinNew Year, New Opportunity! 2 AI Stocks Under $10 Ready to SoarAs we step into 2025, artificial intelligence (AI) stocks continue to dominate headlines, and now is the perfect moment to position yourself for the coming year’s potential. Our latest research has uncovered two must-buy AI stocks currently trading under $10/share – an affordable entry with promising growth potential. These stocks are flying under the radar, but it’s only a matter of time before they gain mainstream attention.👉 Click here to access your FREE report now! Get Venture Life Group News Delivered to You Automatically Sign up to receive the latest news and ratings for VLG and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VLG vs. The Competition Export to ExcelMetricVenture Life GroupDrug Manufacturers IndustryMedical SectorLON ExchangeMarket Cap£51.46M£38.77M£5.17B£1.67BDividend Yield0.09%0.09%5.18%6.88%P/E Ratio4,050.00405.0170.371,799.49Price / Sales1.0052.231,270.96254,755.72Price / Cash6.406.4039.7127.67Price / Book0.693.316.482.83Net Income£2.64M-£6.29M£119.82M£159.82M7 Day Performance-4.14%-5.67%-5.13%-0.63%1 Month Performance-1.34%-11.27%-2.71%3.46%1 Year Performance39.66%-15.55%31.11%127.69% Venture Life Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VLGVenture Life GroupN/AGBX 40.50-2.4%N/A+39.7%£51.46M£51.41M4,050.00165BVXPBioventixN/AGBX 3,825-2.5%N/A+3.4%£199.67M£13.60M2,346.6312News CoverageINSInstemN/AGBX 830flatN/A+0.0%£199.62M£61.63M5,928.57500ARIXArix BioscienceN/AN/AN/AN/A£183.73M£14.16M1,290.919HVOhVIVON/AGBX 26.25-1.9%N/A+41.9%£178.60M£67.21M875.00N/AHigh Trading Volume4BB4basebioN/AGBX 1,325flatN/A+150.0%£169.73M£311,000.00-1,698.72101News CoverageHigh Trading VolumeAVCTAvacta GroupN/AGBX 47+1.1%N/A-65.3%£168.40M£22.62M-522.22120Positive NewsFARNFaron Pharmaceuticals OyN/AGBX 150-1.6%N/A-40.2%£156.93M£-725,000.00-468.7534SCLPScancellN/AGBX 16.25+8.3%N/A+36.8%£151.06M£5.27M-1,625.0051Gap UpANCRAnimalcare GroupN/AGBX 237flatN/A+35.4%£143.08M£76.10M2,962.50220CIRCircassia GroupN/AGBX 34-6.8%N/A+0.0%£142.66M£27.90M3,400.00111Gap Down Related Companies and Tools Related Companies Bioventix Competitors Instem Competitors Arix Bioscience Competitors hVIVO Competitors 4basebio Competitors Avacta Group Competitors Faron Pharmaceuticals Oy Competitors Scancell Competitors Animalcare Group Competitors Circassia Group Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (LON:VLG) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Venture Life Group plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Venture Life Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
